Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 7, 2013, Pages 1466-1476

  Rosenberg, Carina ^a   Bovin, Nicolai V ^b   Bram, Lone Valentin ^c   Flyvbjerg, Eigil ^c   Erlandsen, Mogens ^a   Vorup Jensen, Thomas ^a,d   Petersen, Eskild ^e  

^a AARHUS UNIVERSITY   (Denmark)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c DANFOSS A S   (Denmark)

^d MEMBRANES Research Center   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Caccination; HBsAg; Hepatitis B virus; Immunosenescence; L selectin

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIGEN; L SELECTIN; RECOMBINANT ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGE; AGED; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; SENESCENCE; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

HBSAG; HEPATITIS B VIRUS; IMMUNOSENESCENCE; L-SELECTIN; VACCINATION;

ADULT; AGE FACTORS; AGING; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; L-SELECTIN; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; VACCINATION; VACCINE POTENCY;

EID: 84880913810     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24480     Document Type: Conference Paper

References (57)

1. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011; 54:801-7; PMID:21618565; http://dx.doi.org/10.1002/hep.24442.
2. Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 2011; 17:4853-7; PMID:22171125; http://dx.doi.org/10.3748/wjg.v17.i44.4853.
3. Zuckerman AJ. Novel hepatitis B vaccines. J Infect 1986; 13(Suppl A):61-71; PMID:2427591; http://dx.doi.org/10.1016/S0163-4453(86)92713-1.
4. Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol 2011; 23:237-43; PMID:21257300; http://dx.doi.org/10.1016/j.coi.2010.12.013.
5. Centers for Disease C. Hepatitis B virus. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40(RR-13):1-25; PMID:1835756.
6. Poorolajal J, Mahmoodi M, Haghdoost A, Majdzadeh R, Nasseri-Moghaddam S, Ghalichi L, et al. Booster dose vaccination for preventing hepatitis B. Cochrane database of systematic reviews (Online) 2010; (11):CD008256.
7. Han K, Shao X, Zheng H, Wu C, Zhu J, Zheng X, et al. Revaccination of non- and low-responders after a standard three dose hepatitis B vaccine schedule. Hum Vaccin Immunother 2012; 8:1845-49; PMID:22906933.
8. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000; 19:877-85; PMID:11115711; http://dx.doi.org/10.1016/S0264-410X(00)00224-3.
9. Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, et al. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Vaccine 2011; 29:7835-41; PMID:21816197; http://dx.doi.org/10.1016/ j.vaccine.2011.07.098.
10. Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine 2012; 30:1644-9; PMID:22245310; http://dx.doi.org/10.1016/j. vaccine.2011.12.106.
11. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol 2002; 58:301-4; PMID:12400846.
12. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5:133-9; PMID:14749784; http://dx.doi.org/10.1038/ ni1033.
13. Tohme RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, et al. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities. Vaccine 2011; 29:9316-20; PMID:22015390; http://dx.doi. org/10.1016/j.vaccine.2011.10.011.
14. Williams RE, Sena AC, Moorman AC, Moore ZS, Sharapov UM, Drobenuic J, et al. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine 2012; 30:3147-50; PMID:22421557; http://dx.doi.org/10.1016/j.vaccine.2012.02.078.
15. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31:578-85; PMID:10987724; http://dx.doi.org/10.1086/313947.
16. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine.2005.08.105.
17. Dock JN, Effros RB. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis 2011; 2:382-97; PMID:22308228.
18. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009; 30:306-12; PMID:19540809; http://dx.doi.org/10.1016/j.it.2009.03.013.
19. Jamieson BD, Douek DC, Killian S, Hultin LE, Scripture-Adams DD, Giorgi JV, et al. Generation of functional thymocytes in the human adult. Immunity 1999; 10:569-75; PMID:10367902; http://dx.doi.org/10.1016/S1074-7613(00)80056-4.
20. Hakim FT, Gress RE. Immunosenescence: immune deficits in the elderly and therapeutic strategies to enhance immune competence. Expert Rev Clin Immunol 2005; 1:443-58; PMID:20476994; http://dx.doi.org/10.1586/1744666X.1.3.443.
21. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004; 173:673-81; PMID:15210831.
22. Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 2011; 134:17-32; PMID:21711350; http://dx.doi.org/10.1111/j.1365-2567.2011.03470.x.
23. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 2005; 205:147-57; PMID:15882351; http://dx.doi.org/10.1111/j.0105-2896.2005.00259.x.
24. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence:causes and consequences for immunity in old age. Trends Immunol 2009; 30:325-33; PMID:19541535; http://dx.doi.org/10.1016/j.it.2009.05. 004.
25. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96; PMID:9160750; http://dx.doi.org/10.1016/S0092-8674(00)80240-8.
26. Jacobson EB, Caporale LH, Thorbecke GJ. Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell Immunol 1974; 13:416-30; PMID:4217657; http://dx.doi.org/10.1016/0008-8749(74) 90261-5.
27. Maizels N, Bothwell A. The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell 1985; 43:715-20; PMID:2416469; http://dx.doi.org/10.1016/0092-8674(85)90244-2.
28. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6:1182-90; PMID:16369557; http://dx.doi.org/10.1038/ni1275.
29. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14; PMID:7507411; http://dx.doi.org/10.1016/0092-8674(94)90337-9.
30. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004; 22:129-56; PMID:15032576; http://dx.doi.org/10.1146/annurev. immunol.21.090501.080131.
31. Lowe JB. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 2002; 186:19-36; PMID:12234359; http://dx.doi.org/10.1034/j.1600-065X.2002.18603.x.
32. Harp JR, Onami TM. Naïve T cells re-distribute to the lungs of selectin ligand deficient mice. PLoS One 2010; 5:e10973; PMID:20532047; http://dx.doi.org/10.1371/journal.pone.0010973.
33. Steeber DA, Green NE, Sato S, Tedder TF. Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol 1996; 157:1096-106; PMID:8757614.
34. De Martinis M, Modesti M, Profeta VF, Tullio M, Loreto MF, Ginaldi L, et al. CD50 and CD62L adhesion receptor expression on naive (CD45RA+) and memory (CD45RO+) T lymphocytes in the elderly. Pathobiology 2000; 68:245-50; PMID:11493756;http://dx.doi.org/10.1159/000055933.
35. Chedid MG, Deulofeut H, Yunis DE, Lara-Marquez ML, Salazar M, Deulofeut R, et al. Defect in Th1-like cells of nonresponders to hepatitis B vaccine. Hum Immunol 1997; 58:42-51; PMID:9438208; http://dx.doi.org/10.1016/S0198-8859(97) 00209-7.
36. Gujar SA, Michalak TI. Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection. J Virol 2009; 83:3861-76; PMID:19193791;http://dx.doi.org/10.1128/ JVI.02521-08.
37. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12; PMID:10537110; http://dx.doi.org/10.1038/44385.
38. Kawashima H, Fukuda M. Sulfated glycans control lymphocyte homing. Ann N Y Acad Sci 2012; 1253:112-21; PMID:22288521; http://dx.doi.org/10.1111/j.1749- 6632.2011.06356.x.
39. LeMaoult J, Szabo P, Weksler ME. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev 1997; 160:115-26; PMID:9476670; http://dx.doi.org/10.1111/j.1600-065X.1997.tb01032.x.
40. Goronzy JJ, Weyand CM. T cell development and receptor diversity during aging. Curr Opin Immunol 2005; 17:468-75; PMID:16098723; http://dx.doi.org/10. 1016/j.coi.2005.07.020.
41. Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 2011; 29:2302-7; PMID:21277403; http://dx.doi.org/ 10.1016/j.vaccine.2011.01.025.
42. Chen CY, Hsu HY, Liu CC, Chang MH, Ni YH. Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: A 3-year study of national surveillance of primary school students. Vaccine 2010; 28:5605-8; PMID:20598405; http://dx.doi.org/10.1016/j.vaccine.2010.06.029.
43. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A 2003; 100:15053-8; PMID:14657384; http://dx.doi.org/10.1073/pnas.2433717100.
44. Weksler ME, Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol 2000; 20:240-9; PMID:10939711; http://dx.doi.org/10.1023/A: 1006659401385.
45. Aberle JH, Stiasny K, Kundi M, Heinz FX. Mechanistic insights into the impairment of memory B cells and antibody production in the elderly. Age 2013; 35:371-81; PMID:22282053.
46. Goodell V, dela Rosa C, Slota M, MacLeod B, Disis ML. Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses. BMC Immunol 2007; 8:21; PMID:17850666; http://dx.doi.org/10.1186/1471-2172-8-21.
47. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev 1996; 86:173-95; PMID:8733112;http://dx.doi.org/10.1016/0047-6374(95)01691-0.
48. Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005; 114:37-43;PMID:15606793; http://dx.doi.org/10.1111/j.1365-2567.2004.02006.x.
49. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, et al. T cells and aging, January 2002 update. Front Biosci 2002; 7:d1056-183; PMID:11991846.
50. Leid JG, Jutila MA. Impact of polyunsaturated fatty acids on cytoskeletal linkage of L-selectin. Cell Immunol 2004; 228:91-8; PMID:15219460; http://dx.doi.org/10.1016/j.cellimm.2004.04.004.
51. Mattila PE, Green CE, Schaff U, Simon SI, Walcheck B. Cytoskeletal interactions regulate inducible L-selectin clustering. Am J Physiol Cell Physiol 2005; 289:C323-32; PMID:15788481; http://dx.doi.org/10.1152/ajpcell. 00603.2004.
52. Bakker GJ, Eich C, Torreno-Pina JA, Diez-Ahedo R, Perez-Samper G, van Zanten TS, et al. Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion. Proc Natl Acad Sci U S A 2012; 109:4869-74; PMID:22411821; http://dx.doi.org/10.1073/pnas.1116425109.
53. Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, Walse B, et al. The interaction properties of costimulatory molecules revisited. Immunity 2002; 17:201-10; PMID:12196291; http://dx.doi.org/10.1016/S1074-7613(02)00362-X.
54. Cohen M, Varki A. The sialome-far more than the sum of its parts. OMICS 2010; 14:455-64; PMID:20726801; http://dx.doi.org/10.1089/omi.2009.0148.
55. Ogiso M, Irie A, Kubo H, Hoshi M, Komoto M. Senile cataract-related accumulation of Lewis(x) glycolipid in human lens. J Biol Chem 1992; 267:6467-70;PMID:1348055.
56. Gironella M, Mollà M, Salas A, Soriano A, Sans M, Closa D, et al. The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice. J Leukoc Biol 2002; 72:56-64; PMID:12101263.
57. Tung JW, Parks DR, Moore WA, Herzenberg LA, Herzenberg LA. New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol 2004; 110:277-83; PMID:15047205; http://dx.doi.org/10.1016/j.clim.2003.11.016.